Egalet's morphine sulfate extended-release tablets with proposed abuse-deterrent formulation
Read MoreJUN 8 AADPAC-DSRM
Pfizer's oxycodone/naltrexone extended-release capsules for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It has been formulated with the intent to provide abuse-deterrent properties.
Read MoreJUN 7 AADPAC-DSRM
Teva's hydrocodone bitartrate extended-release tablets for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
Read MoreJUN 8 AADPAC-DSRM
Pfizer's oxycodone/naltrexone extended-release capsules for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It has been formulated with the intent to provide abuse-deterrent properties.
Read MoreJUN 7 AADPAC-DSRM
Teva's hydrocodone bitartrate extended-release tablets for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
Read MoreJUN 8 AADPAC-DSRM-BA
Pfizer's oxycodone/naltrexone extended-release capsules for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It has been formulated with the intent to provide abuse-deterrent properties.
Read MoreJUN 7 AADPAC-DSRM
Teva's hydrocodone bitartrate extended-release tablets for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
Read MoreSEP 15-16 PEDAC AADPAC DSRM
Development plans for establishing the safety and efficacy of prescription opioid analgesics for pediatric patients, including obtaining pharmacokinetic data and the use of extrapolation
Read MoreSEP 11 AADPAC
Collegium's oxycodone extended-release tablets: food effects and abuse deterrence
Read MoreSEP 10 AADPAC
Purdue’s oxycodone immediate-release tablets: food effects and abuse deterrence
Read MoreSEP 11 AADPAC-DSRM
Collegium's Xtampza (oxycodone extended-release tablets): food effects and abuse deterrence
Read MoreSEP 10 AADPAC-DSRM
Purdue’s Avridi (oxycodone immediate-release tablets): food effects and abuse deterrence
Read MoreSEP 11 AADPAC-DSRM
Collegium's oxycodone extended-release tablets: food effects and abuse deterrence
Read MoreSEP 10 AADPAC-DSRM
Purdue’s oxycodone immediate-release tablets: food effects and abuse deterrence
Read MoreSEP 11 AADPAC-DSRM
Collegium's oxycodone extended-release tablets: food effects and abuse deterrence
Read MoreSEP 10 AADPAC-DSRM
Purdue’s oxycodone immediate-release tablets: food effects and abuse deterrence
Read MoreNOV 24-25 AADPAC
Risk of serious neurologic reactions with epidural steroid injections
Read MoreNOV 24-25 AADPAC
Risk of serious neurologic reactions with epidural steroid injections
Read MoreNOV 24-25 AADPAC
Risk of serious neurologic adverse reactions with epidural steroid injections
Read More